Changes in the USP heparin monograph and implications for clinicians

Pharmacotherapy. 2010 May;30(5):428-31. doi: 10.1592/phco.30.5.428.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / chemistry
  • Anticoagulants / standards*
  • Anticoagulants / therapeutic use*
  • Chemistry, Pharmaceutical
  • Drug Contamination / prevention & control
  • Drug Monitoring
  • Heparin / administration & dosage
  • Heparin / chemistry
  • Heparin / standards*
  • Heparin / therapeutic use*
  • Humans
  • Pharmacopoeias as Topic
  • Prothrombin / antagonists & inhibitors
  • Reference Standards
  • Societies, Medical
  • United States
  • United States Food and Drug Administration
  • World Health Organization

Substances

  • Anticoagulants
  • Prothrombin
  • Factor IIa
  • Heparin